EMEA-001514-PIP01-13-M01
Key facts
| Invented name |
Laryngomedin Octenidin Antisept and associated names
|
| Active substance |
octenidine dihydrochloride
|
| Therapeutic area |
Oto-rhino-laryngology
|
| Decision number |
P/0269/2019
|
| PIP number |
EMEA-001514-PIP01-13-M01
|
| Pharmaceutical form(s) |
Lozenge
|
| Condition(s) / indication(s) |
Treatment of upper respiratory tract infections
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Cassella-med GmbH & Co. KG
Tel. +49 221165200 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-001514-PIP01-13-M01
|
| Compliance opinion date |
11/12/2019
|
| Compliance outcome |
positive
|